HYPERTRIGLYCERIDEMIA
Clinical trials for HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RNA drug shows promise for Hard-to-Treat cholesterol disorders
Disease control CompletedThis early-stage study tested a new medicine called ARO-ANG3 in 93 healthy adults and people with high cholesterol or high triglycerides. The main goal was to see if the drug is safe and how the body processes it. This is a first step toward a possible new treatment for lipid dis…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:19 UTC
-
New drug olezarsen shows promise in lowering dangerous fat levels in the blood
Disease control CompletedThis study tested a new medicine called olezarsen in about 1,500 adults with very high triglycerides (a type of blood fat) who also had heart disease or were at high risk for it. The goal was to see if olezarsen could lower triglyceride levels more than a placebo over 25 weeks. P…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug MAR001 targets high triglycerides in early trial
Disease control CompletedThis early-stage study tested the safety and tolerability of a new drug called MAR001 in 55 adults with high triglycerides (a type of fat in the blood). The main goal was to see if the drug is safe, and researchers also checked whether it lowers triglyceride levels. The study was…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1, PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Omega-3s tested for heart health in overweight chileans
Disease control CompletedThis study looked at whether omega-3 fatty acids (fish oil) can improve cholesterol levels and reduce inflammation in overweight or obese adults with high triglycerides. Forty participants took omega-3 supplements or a placebo in a crossover design. The goal was to see if a simpl…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: NA • Sponsor: Universidad San Sebastián • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo pill aims to lower dangerous blood fats
Disease control CompletedThis study tested a medication called Cipros 10 in 146 adults with high cholesterol and triglycerides. The goal was to see if it safely lowers blood fat levels. Participants took the drug or a placebo for a set period, and researchers measured changes in triglycerides and tracked…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug targets dangerous fat levels in blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-APOC3 in healthy people and those with extremely high triglycerides (blood fats), including a rare genetic condition called familial chylomicronemia syndrome. The main goal was to check safety and how the drug moves through …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New drug shows promise for lowering dangerous fat levels in the blood
Disease control CompletedThis study tested an experimental drug called olezarsen in 154 adults with very high triglycerides (a type of blood fat) and either heart disease or a high risk for it. The goal was to see if the drug could safely lower triglyceride levels more than a placebo over 6 and 12 months…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New cholesterol drug VSA003 passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body processes it. Participants had slightly high cholesterol or triglycerides. The goal was not to treat disease but to gather safety and drug-level data before mo…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC